תוצאות חיפוש - Gee‐Chen Chang
- Showing 1 - 20 results of 49
- Go to Next Page
-
1
-
2
Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer מאת Sheng-Yi Lin, Hsiu-Hui Chang, Yi-Hua Lai, Ching‐Hsiung Lin, Min-Hsuan Chen, Gee‐Chen Chang, Meng-Feng Tsai, Jeremy J.W. Chen
יצא לאור 2015Artigo -
3
Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy מאת Jen‐Yi Lee, Yee-Ming Lee, Gee‐Chen Chang, Sung‐Liang Yu, Wan-Yu Hsieh, Jeremy J.W. Chen, Huei‐Wen Chen, Pan‐Chyr Yang
יצא לאור 2011Artigo -
4
P2.14-59 Osimertinib in EGFR T790M Advanced NSCLC: Analysis of Uncommon/Complex EGFR Mutations in a Real-World Study (ASTRIS) מאת Parneet Cheema, Antonio Passaro, Charles E. Martin, Marcello Tiseo, K. Park, Gee‐Chen Chang, Yang Hu, Byoung Chul Cho, Margarida S. Miranda, A. Fernandes, H. Freitas
יצא לאור 2019Artigo -
5
-
6
-
7
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients מאת Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Tsung‐Ying Yang, Kun‐Chieh Chen, Kang‐Yi Su, Sung‐Liang Yu, Jeremy J.W. Chen, Yen-Hsiang Huang, Gee‐Chen Chang
יצא לאור 2022Artigo -
8
-
9
-
10
-
11
A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma מאת Tony Mok, Sarayut Lucien Geater, Wu‐Chou Su, Eng-Huat Tan, James Chih‐Hsin Yang, Gee‐Chen Chang, May Han, Philip Komarnitsky, Francis Payumo, Jennifer Garrus, Sandra Close, Keunchil Park
יצא לאור 2016Artigo -
12
Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma מאת Jeng‐Sen Tseng, Tsung‐Ying Yang, Chi‐Ren Tsai, Kun‐Chieh Chen, Kuo-Hsuan Hsu, Meen-Hsin Tsai, Sung‐Liang Yu, Kang‐Yi Su, Jeremy J.W. Chen, Gee‐Chen Chang
יצא לאור 2014Artigo -
13
Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target מאת Kuan-Chung Hsiao, Neng-Yao Shih, Hsun-Lang Fang, Tze‐Sing Huang, Ching-Chuan Kuo, Pei‐Yi Chu, Yi‐Mei Hung, Shao-Wen Chou, Yi-Yuan Yang, Gee‐Chen Chang, Ko-Jiunn Liu
יצא לאור 2013Artigo -
14
Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program מאת Solange Peters, Alessandra Curioni‐Fontecedro, Hovav Nechushtan, Jin‐Yuan Shih, Wei‐Yu Liao, Oliver Gautschi, Vito Spataro, Mojca Unk, James Chih‐Hsin Yang, Robert M. Lorence, Philippe Carrière, A. Cseh, Gee‐Chen Chang
יצא לאור 2018Artigo -
15
MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC מאת Yi‐Long Wu, Byoung Chul Cho, Qing Zhou, Gee‐Chen Chang, Liyan Jiang, Giulio Metro, Claudio Martín, Gilberto de Castro, Johan Vansteenkiste, David Vicente, A. Milner, James R. Rigas, Y. Chen, Mariano Provencio
יצא לאור 2018Artigo -
16
Pretreatment Epidermal Growth Factor Receptor (<i>EGFR</i>) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Ca... מאת Kang‐Yi Su, Hsuan‐Yu Chen, Ker-Chau Li, Min‐Liang Kuo, James Chih‐Hsin Yang, Wing‐Kai Chan, Bing‐Ching Ho, Gee‐Chen Chang, Jin‐Yuan Shih, Sung‐Liang Yu, Pan‐Chyr Yang
יצא לאור 2012Artigo -
17
HOXA5 Inhibits Metastasis via Regulating Cytoskeletal Remodelling and Associates with Prolonged Survival in Non-Small-Cell Lung Carcinoma מאת Chi-Chung Wang, Kang‐Yi Su, Hsuan‐Yu Chen, So-Yi Chang, Chi-Fan Shen, Chia-Hung Hsieh, Qi-Sheng Hong, Ching-Cheng Chiang, Gee‐Chen Chang, Sung‐Liang Yu, Jeremy J.W. Chen
יצא לאור 2015Artigo -
18
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarc... מאת Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Kun‐Chieh Chen, Chia-Hung Hsu, Kang‐Yi Su, Jeremy J.W. Chen, Huei‐Wen Chen, Sung‐Liang Yu, Tsung‐Ying Yang, Gee‐Chen Chang
יצא לאור 2018Artigo -
19
Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report מאת James Chih‐Hsin Yang, Frances A. Shepherd, Dong‐Wan Kim, Gyeong‐Won Lee, Jong Seok Lee, Gee‐Chen Chang, Sung Sook Lee, Yu‐Feng Wei, Yun Gyoo Lee, Gianluca Laus, Barbara Collins, Francesca Pisetzky, Leora Horn
יצא לאור 2019Artigo -
20
כלי חיפוש:
נושאים קשורים
Medicine
Cancer
Internal medicine
Biology
Lung cancer
Oncology
Genetics
Gene
Cancer research
Epidermal growth factor receptor
Adenocarcinoma
Gefitinib
Gastroenterology
Biochemistry
Confidence interval
T790M
Erlotinib
Genotype
Single-nucleotide polymorphism
Pathology
Genome-wide association study
Osimertinib
Cell biology
Genetic association
Metastasis
Adverse effect
Environmental health
Bioinformatics
Chemotherapy
Clinical endpoint